Xgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XGEN PHARMS, and what generic and branded alternatives to XGEN PHARMS drugs are available?
XGEN PHARMS has nineteen approved drugs.
Drugs and US Patents for Xgen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xgen Pharms | DACTINOMYCIN | dactinomycin | INJECTABLE;INJECTION | 203999-001 | May 20, 2019 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Xgen Pharms | NEOMYCIN AND POLYMYXIN B SULFATE | neomycin sulfate; polymyxin b sulfate | SOLUTION;IRRIGATION | 065106-001 | Jan 31, 2006 | AT | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Xgen Pharms | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | INJECTABLE;INJECTION | 040737-002 | Apr 24, 2008 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Xgen Pharms | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | INJECTABLE;INJECTION | 040737-001 | Apr 24, 2008 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Xgen Pharms | EDARAVONE | edaravone | SOLUTION;INTRAVENOUS | 217565-002 | Oct 31, 2024 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Xgen Pharms | CLONIDINE HYDROCHLORIDE | clonidine hydrochloride | INJECTABLE;INJECTION | 203167-001 | Oct 29, 2013 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Xgen Pharms | FOLIC ACID | folic acid | INJECTABLE;INJECTION | 202522-001 | Nov 6, 2019 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.